Alnylam Hits Pfizer, Moderna With Patent Infringement Suits

Alnylam Pharmaceuticals Inc ALNY has filed separate lawsuits in the Delaware federal court against Pfizer Inc PFE and Moderna Inc MRNA, seeking damages for infringement of a patent in the manufacture and sale of their mRNA COVID-19 vaccines.
Alnylam said it was seeking compensation for the use of its lipid nanoparticles (LNP) technology that carries and delivers RNA-based therapeutics or vaccines in the body.
The pharmaceutical firm said that Pfizer and Moderna's vaccines infringe Alnylam's patent by using a lipid formulated into LNPs that protect and deliver the vaccines' mRNA.
Read Next: Arbutus Hits Moderna With New Suit Claiming COVID-19 Vaccine Patent(s).
Alnylam said it does not intend to take action that impedes the vaccines' production, sale, or distribution.
Price Action: PFE stock is up 2.15% at $54.06 during the market session on the last check Thursday.